Call for Abstracts

The 15th Australasian Cystic Fibrosis Conference will be held on the 2 - 4 August 2024 at the Brisbane Convention & Exhibition Centre, Queensland. 

The 2024 Australasian Cystic Fibrosis Conference invites abstract submissions from delegates and offers authors the opportunity to share their vision and experience on topics that align with the conference theme.

The theme of the Australasian Cystic Fibrosis Conference 2024 is “Connect and Conquer: Advancing CF Care.”

These recent years have witnessed extraordinary adaptations and innovations within the Cystic Fibrosis community. Our theme, “Connect and Conquer: Advancing CF Care" will delve into these remarkable developments across all facets of healthcare, from pioneering research to real-world applications of cutting-edge technologies. We eagerly anticipate your participation. Your presence will contribute to the success of this significant event. We look forward to welcoming you to the Brisbane Convention and Exhibition Centre in August 2024.

IMPORTANT DATES

ABSTRACT PORTAL OPENS WEEK COMMENCING MONDAY 29 JANUARY, 2024
SUBMISSIONS CLOSE TUESDAY 19 MARCH, 2024

ABSTRACT FORMATTING INSTRUCTIONS TO AUTHORS

Title:

  • Type in UPPER CASE
  • Do not identify yourself or institution in the title
  • Limit to 15 words

Body of Abstract: 

  • all abstracts to be written in English
  • use Sentence case
  • maximum word count must not exceed 300 words
  • must not contain tables, pictures or diagrams
  • abbreviations should conform with uniform requirements of manuscripts submitted to scientific journals. References are not required but may be included
  • body to consist of 4 paragraphs: Background, Methods, Results and Conclusions 
  • abstracts should not contain proprietary or confidential information
  • standard abbreviations are acceptable. Any special abbreviations should be given in parenthesis after the first appearance of the full word or phase for which it stands
  • place acknowledgements at the end of the abstract, e.g., supported by…

Drug Names

If the brand-name drug has a generic version, the generic names(s) should be used for all drugs that qualify-provide definition once, e.g., “lumacaftor/ivacaftor (Orkambi)”; use generic thereafter. If using brand-name drugs, they need to be company agnostic, not promotional, and consistent throughout your abstract(s) and presenting materials (poster/oral presentation/PowerPoint slides, etc.).

ADDITIONAL INFORMATION

All expenses associated with the submission and presentation of the abstract are the presenter’s responsibility.

Submission constitutes a commitment from the author(s) to present their poster if the abstract is accepted.

For more information and to submit an abstract please click on the button below. 

The 15th Australasian Cystic Fibrosis Conference will be held on the 2 - 4 August 2024 at the Brisbane Convention & Exhibition Centre, Queensland. 

www.acfconference.com.au

Iceberg Events | PO Box 1179, Milton QLD Australia | Phone +61 7 3876 4988       

© Iceberg Events Conference & Event Management